This is a SEO version of PAM_350. Click here to view full version
« Previous Page Table of Contents Next Page »86 Panorama Actual del Medicamento
NUEVOS FÁRMACOS
MEDICAMENTOS DADOS DE BAJA (ENERO 2012)
CÓDIGO NOMBRE, PRESENTACIÓN Y LABORATORIO FECHA
7488712 BUSPAR 10 MG 30 COMPRIMIDOS (BRISTOL MYERS SQUIBB)........................................................................................ 2-2012 6836125 ST CANDESARTAN STADA EFG 16 MG 28 COMPRIMIDOS (STADA S.L)............................................................................... 2-2012 6835937 ST CANDESARTAN STADA EFG 32 MG 28 COMPRIMIDOS (STADA S.L)............................................................................... 2-2012 6835821 ST CANDESARTAN STADA EFG 4 MG 14 COMPRIMIDOS (STADA S.L)................................................................................. 2-2012 6835630 ST CANDESARTAN STADA EFG 8 MG 28 COMPRIMIDOS (STADA S.L)................................................................................. 2-2012 6836323 ST CANDESARTAN/HIDROCLOROTIAZIDA STADA EFG 16/12.5 MG 28 COMPRIMIDOS (STADA S.L)................................ 2-2012 6725207 CLOPIDOGREL ESP PHARMA EFG 75 MG 28 COMPRIMIDOS RECUBIERTOS (ESP PHARMA). ................................... 2-2012 6589878 ENALAPRIL+HCTZ ANGENERICO EFG 20/12.5 MG 28 COMPR (ANGENERICO S.L.). ..................................................... 2-2012 6533413 ST EPILEXTER 60 MG/ML SUSPENSION ORAL 250 ML (ESTEVE).......................................................................................... 2-2012 6383049 FELDENE 20 MG 500 COMPR DISPERS (NEFOX FARMA).................................................................................................. 2-2012 6632772 LETROZOL CINFAMED EFG 2.5 MG 30 COMPRIMIDOS CUBIERTA PELICULAR (CINFA)............................................... 1-2012 6888469 MAXIPIME 500 MG IM/IV 1 VIAL 5 ML (BRISTOL MYERS SQUIBB)..................................................................................... 2-2012 6658772 MERIGEST SEQUI “1 MG” 28 COMPRIMIDOS (NOVARTIS FARMACEUTICA)................................................................... 1-2012 9289034 MYCOSTATIN TOPICO 100000 U POMADA 30 G (BRISTOL MYERS SQUIBB).................................................................. 2-2012 8018291 NECOPEN 100 MG/5 ML SUSP 100 ML (ESTEVE)................................................................................................................ 2-2012 6435281 NECOPEN 100 MG/5 ML SUSP 100 ML 20 FRAS (ESTEVE)................................................................................................ 2-2012 8033874 NECOPEN 100 MG/5 ML SUSP 50 ML (ESTEVE).................................................................................................................. 2-2012 6435106 NECOPEN 100 MG/5 ML SUSP 50ML 20FRAS (ESTEVE).................................................................................................... 2-2012 6618783 PERINDOPRIL ACTAVIS 2 MG 30 COMPRIMIDOS (ACTAVIS SPAIN S.A.). ....................................................................... 2-2012 6637463 QUINAPRIL/HIDROCLOROTIAZIDA MITHRIDATUM 20/25 MG 28 COMPRIMIDOS RECUBIERTOS................................. 2-2012 (MITHRIDATUM)
6637456 QUINAPRIL/HIDROCLOROTIAZIDA MITHRIDATUM EFG 20/12.5 MG 28 COMPRIMIDOS RECUBIERTOS...................... 2-2012 (MITHRIDATUM)
6832721 ST RILUZOL SPI EFG 50 MG 56 COMPRIMIDOS (BLISTER AL/AL) (SWAN POND INVESTMENTS LIMITED)...................... 1-2012 6832738 ST RILUZOL SPI EFG 50 MG 56 COMPRIMIDOS (BLISTER PVC/AL) (SWAN POND INVESTMENTS LIMITED)................... 1-2012 6832707 ST RILUZOL SWANPOND INVESTMENT EFG 50 MG 56 COMPRIMIDOS (BLISTER AL/AL) (SWAN POND.......................... 1-2012 INVESTMENTS LIMITED)
6832714 ST RILUZOL SWANPOND INVESTMENT EFG 50 MG 56 COMPRIMIDOS (BLISTER PVC/AL) (SWAN POND....................... 1-2012 INVESTMENTS LIMITED)
7427421 ROZEX 0.75% CREMA 30 G (GALDERMA)............................................................................................................................ 2-2012 7845874 ST TADEGAN 10 MG 30 COMPRIMIDOS (TARBIS FARMA, S.L.).............................................................................................. 2-2012 7845799 ST TADEGAN 5 MG 30 COMPRIMIDOS (TARBIS FARMA, S.L.)................................................................................................ 2-2012 6612583 VENLAFAXINA FARMAPROJECTS 25 MG 30 COMPRIMIDOS (FARMAPROJECTS S.A.)................................................. 2-2012 6612590 VENLAFAXINA FARMAPROJECTS EFG 37.5 MG 30 COMPRIMIDOS (FARMAPROJECTS S.A.)...................................... 2-2012 6612613 VENLAFAXINA FARMAPROJECTS EFG 50 MG 30 COMPRIMIDOS (FARMAPROJECTS S.A.)......................................... 2-2012 6612620 VENLAFAXINA FARMAPROJECTS EFG 75 MG 30 COMPRIMIDOS (FARMAPROJECTS S.A.)......................................... 2-2012 6612637 VENLAFAXINA FARMAPROJECTS EFG 75 MG 60 COMPRIMIDOS (FARMAPROJECTS S.A.)......................................... 2-2012
652777 36,37 IGANTIBE 200UI/ML 0,5ML CON 100UI INYECTABLE 738088 652778 193,14 IGANTIBE 200UI/ML 3ML CON 600UI INYECTABLE 709238 652785 295,27 IGANTIBE 200UI/ML 5ML CON 1000UI INYECTABLE 708958 653643 51,16 INNOHEP 10.000 UI/ml EN, 10 jer 0,45 ml 814970 653635 10,24 INNOHEP 10.000 UI/ml EN 2 jer 0,45 ml 814905 653684 114,68 INNOHEP 20.000 UI ANTI-XA/ml 10 jer 0,5 ml 745216 653660 23,54 INNOHEP 20.000 UI ANTI-XA/ml 2 jer 0,5 ml 745190 653676 36,79 INNOHEP 20.000 UI ANTI-XA/ml 2 jer 0,9 ml 746107 653710 245,61 INNOHEP 20.000 UI ANTI-XA/ml 30 jer 0,5 ml 659742 653721 363,19 INNOHEP 20.000 UI ANTI-XA/ml 30 jeringas 0,9 ml 659744 653718 298,20 INNOHEP 20.000 UI ANTI-XA/ml 30 jer 0,7 ml 659743 653692 167,53 INNOHEP 20.000 UI ANTI-XA/ml 10 jer 0,9 ml 746461 653668 29,13 INNOHEP 20.000 UI ANTI-XA/ml 2 jer de 0,7 ml 745422 653726 142,14 INNOHEP 20.000 UI ANTI-XA/ml 10 jer de 0,7 ml 745869 652769 3386,90 SPRYCEL 50MG 56COMPRIMIDOS 656419 652751 3386,90 SPRYCEL 50MG 56COMPRIMIDOS 656420
CN Nuevo PRECIO NOMBRE Y PRESENTACIÓN CN Antiguo
CAMBIO DE CÓDIGO NACIONAL Y PRECIO
MODIFICACIONES DE MEDICAMENTOS FEBRERO 2012
This is a SEO version of PAM_350. Click here to view full version
« Previous Page Table of Contents Next Page »